Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06720155 · ClinicalTrials.gov registry record · NA

Sleeper Stretch in CrossFit Participants

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT06720155: Completed NA study, sponsored by Mayo Clinic.

NCT06720155 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06720155, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

The purpose of this study is to compare the efficacy of the sleeper stretch in improving shoulder range of motion, strength and upper body performance in CrossFit athletes.

Primary Outcome

Measured by isometric horizontal push test (IHPT), a newly designed test that selectively measures the horizontal component of maximal isometric force, with 3 minutes of rest between each trial. The participants will place their hands on force platforms that sample ground reaction force data at 1000 Hz throughout the test.

Interventions

  • BEHAVIORAL Sleeper stretch
  • BEHAVIORAL Standard workout

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2025-05-15
Est. Completion 2025-09-30
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT06720155 record still lists

NCT06720155 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Sleeper stretch is the first listed.

NCT06720155 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06720155 about?

NCT06720155 is a clinical study titled "Sleeper Stretch in CrossFit Participants". The purpose of this study is to compare the efficacy of the sleeper stretch in improving shoulder range of motion, strength and upper body performance in CrossFit athletes.

What is the current status of trial NCT06720155?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2025-05-15. Estimated completion is 2025-09-30.

What interventions are being tested in trial NCT06720155?

The interventions under investigation include: Sleeper stretch (BEHAVIORAL), Standard workout (BEHAVIORAL).

Who is sponsoring clinical trial NCT06720155?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06720155's enrollment target sits among peer trials

26 1710th of 2000 higher than 289 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06720155, the US trial registry maintained by the National Library of Medicine. NCT06720155 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.